Search Results 991-1000 of 16145 for pharmacogenetics
ROCHESTER, Minn. — Early detection is key to breast cancer survival. But nearly half of all women in the U.S. have dense breast tissue, which can make ...
In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the Investigator's ...
A Study Comparing the Effectiveness of Tiotropium and Olodaterol in Fixed Dose Combination Over Tiotropium Alone in Reducing Moderate to Severe Wosening of ...
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
The purpose of this study is to create a biorepository of tissue, fluid and fungal specimens for future studies. Participation eligibility. Participant ...
ROCHESTER, Minn. — Mayo Clinic has been selected to lead a groundbreaking research project focused on improving indoor air quality and safety in healthcare ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping ...
Latest stories · Education · Mayo Clinic Radio: National Nutrition Month featured image · Heart failure more likely for some breast cancer and lymphoma survivors ...
Nearly half of all women who have had a mammogram to screen for breast cancer have been identified as having dense breasts. This makes it more[...] ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.